Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world’s first academic Institute focused on young athletes’ safety and lifelong health and will combine Oxford’s longstanding tradition in sports and education with the very best of science, medicine, and technology.

Student looking at a brain scan

The new Institute will shift the traditional emphasis of research into sports injury - which is predominantly adult-centric and based upon treatment – by concentrating on younger athletes, 11-18 years old, and will focus on prevention rather than cure.

The institute will develop new technologies to monitor and analyse the individual factors that currently lead to youth sports injuries and offer practical solutions for safer sports practices, focusing on safety for lifelong health, rather than performance.

‘Sport-related injury, particularly concussion, have rapidly risen to the top of under-reported and under-researched issues with lifelong consequences for both individual athletes and society. This partnership, and the new Institute, will combine the best of science, medicine and technology to deliver research that can have a real-world and measurable impact on young people’s lives.’ Prof Louise Richardson, Vice-Chancellor of the University of Oxford 

The Institute will form part of the Institute of Biomedical Engineering (Department of Engineering Science) - which has a 15-year track-record of combining medicine and technology to achieve adoption and healthcare impact - and will draw on leading expertise across the medical sciences, including clinical neurosciences, orthopaedics, and population health, as well as Oxford’s Big Data Institute

Read the full story on the University of Oxford website

Similar stories

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

Showcase success for Science Together research

A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford’s Old Fire Station.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.